Table 3.
Best corrected visual acuity | Preplaque brachytherapy | 2–4 months | 5–7 months | 8–14 months | 15–20 months | 21–27 months | 28–33 months | 34+ months |
---|---|---|---|---|---|---|---|---|
20/20 or better | 25.9% | 25.9% | 25.9% | 28.9% | 31.2% | 40.3% | 26.5% | 23.1% |
20/25–20/50 | 58.0% | 58.1% | 56.8% | 59.2% | 59.7% | 58.2% | 67.4% | 76.9% |
20/60–20/80 | 8.7% | 12.3% | 12.3% | 6.6% | 3.9% | 1.5% | 6.1% | 0% |
20/100–20/160 | 3.7% | 2.5% | 3.7% | 3.9% | 2.6% | 0.0% | 0.0% | 0% |
20/200–20/320 | 2.5% | 1.2% | 1.2% | 0.0% | 1.3% | 0.0% | 0.0% | 0% |
20/400–20/640 | 1.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0% |
20/800 or worse | 0.0% | 0.0% | 0.0% | 1.3% | 1.3% | 0.0% | 0.0% | 0% |
Total patients | 81 | 81 | 81 | 76 | 77 | 67 | 49 | 39 |
Mean visual acuity | 20/35 | 20/34 | 20/34 | 20/33 | 20/33 | 20/29 | 20/31 | 20/30 |
Notes: Patients include those that developed radiation maculopathy and maintained 20/50 or better vision at their final follow-up visit (n = 81).